Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.
Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This is a minor metadata update.SummaryDifference0.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedLocations section updated with numerous new study sites across the US, Australia, Canada, and multiple other regions. Several previously listed sites were removed or reorganized.SummaryDifference2%
- Check53 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.0%
- Check60 days agoChange DetectedThe additions update PubMed source wording and add Revision: v3.3.1; the deletions adjust the PubMed sourcing language and add Revision: v3.2.0.SummaryDifference0.0%
- Check67 days agoChange DetectedAdded a study location: Tainan, Taiwan, 70457. The listing was updated to standardize the location as 'Tainan, Taiwan, 70457' and a government funding status notice was removed.SummaryDifference0.2%
- Check82 days agoChange DetectedNo significant changes to the core content; the study details, eligibility criteria, and outcomes appear unchanged, with only minor visual/layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.